SERB Pharmaceuticals strengthens leadership in medical countermeasures with the global acquisition of RSDL® (Reactive Skin Decontamination Lotion) kit for $75 million
31 juil. 2024 09h06 HE
|
SERB Pharmaceuticals
Philadelphia, PA, July 31, 2024 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals, a global specialty pharmaceutical company, announced today the acquisition of RSDL® (Reactive Skin Decontamination Lotion)...
Chemical, Biological, Radiological & Nuclear (CBRN) Defence market is projected to grow at a CAGR of 5.1% by 2034: Visiongain
11 oct. 2023 10h52 HE
|
Visiongain Reports Ltd
Visiongain has published a new report entitled Chemical, Biological, Radiological & Nuclear (CBRN) Defence Market Report 2024-2034: Forecasts by End-user (Military Forces, Homeland Security...
BTG Pharmaceuticals, a SERB company, to present data on ricin antidote development programme at the North American Congress of Clinical Toxicology
21 sept. 2023 06h42 HE
|
BTG Specialty Pharmaceuticals
West Conshohocken, PA, Sept. 21, 2023 (GLOBE NEWSWIRE) -- BTG Pharmaceuticals, a SERB company, announced today that SERB will present in vivo data for PR022, a polyclonal antibody in development as...
GST Awarded as a Prime Contractor on $900 Million Four-Year Base JE-CLaSS II Contract
03 févr. 2023 12h00 HE
|
Global Systems Technologies, Inc.
YARDLEY, Pa., Feb. 03, 2023 (GLOBE NEWSWIRE) -- Global Systems Technologies, Inc. (GST) has been awarded a $900 million, four-year base and one four-year option period contract to support the Joint...
CBRN Protection Equipment Market to Exceed US$ 8,306.4 Mn by 2029 Driven by Increasing Military Threats | Future Market Insights, Inc.
28 juil. 2022 06h00 HE
|
Future Market Insights Global and Consulting Pvt. Ltd.
NEWARK, Del, July 28, 2022 (GLOBE NEWSWIRE) -- The global CBRN protection equipment is projected to reach a value of US$8,306.4 Mn in 2029, with sales growing at a moderate CAGR of 5.5%. The market...
SERB Pharmaceuticals licenses Soligenix antigen to develop ricin antidote
14 juil. 2022 07h01 HE
|
BTG Specialty Pharmaceuticals
Philadelphia, July 14, 2022 (GLOBE NEWSWIRE) -- SERB Pharmaceuticals has signed a worldwide exclusive license to use an antigen from Soligenix [NSDQ: SNGX] to develop a novel therapeutic treatment...
Chemical, Biological, Radiological, and Nuclear (CBRN) Security Market to Garner $28.68 Billion by 2030: Allied Market Research
21 sept. 2021 17h00 HE
|
Allied Market Research
Portland, OR, Sept. 21, 2021 (GLOBE NEWSWIRE) -- According to the report published by Allied Market Research, the global chemical, biological, radiological, and nuclear (CBRN) security market...
SERSTECH AB: Serstech receives EU funding for CBRN project
14 août 2020 06h00 HE
|
Serstech
A consortium of public and private organizations, of which Serstech is part, has been granted funding from the European Commission. The project aims to develop technologies, based on Raman and SERS...
The Chemical, Biological, Radiological and Nuclear (CBRN) Defence Market Set to Grow to $15,193mn by 2029, Says Visiongain Report.
01 avr. 2019 10h59 HE
|
Visiongain Ltd
London, UK, April 01, 2019 (GLOBE NEWSWIRE) -- CBRN or the Chemical, Biological, radiological and Nuclear Defence means the precautions or the protective measures which are taken in case of such...
Battelle Wins Joint Enterprise Contracted Logistics and Services Support (JE-CLaSS) Contract to Provide Broad Array of Chemical and Biological Defense Technical Services
27 janv. 2016 12h37 HE
|
Battelle
COLUMBUS, OH--(Marketwired - January 27, 2016) - Battelle recently was named a qualifying contractor to bid for chemical and biological defense work for the next five years under the $900 million...